A Pharmaceutical Paradigm for Cardiovascular Composite Risk Assessment Using Novel Radiogenomics Risk Predictors in Precision Explainable Artificial Intelligence Framework: Clinical Trial Tool

Saba Luca and Maindarkar Mahesh and Khanna Narendra N. and Johri Amer M. and Mantella Laura and Laird John R. and Paraskevas Kosmas I. and Ruzsa Zoltán and Kalra Manudeep K. and Fernandes Jose Fernandes E. and Chaturvedi Seemant and Nicolaides Andrew and Rathore Vijay and Singh Narpinder and Fouda Mostafa M. and et al.: A Pharmaceutical Paradigm for Cardiovascular Composite Risk Assessment Using Novel Radiogenomics Risk Predictors in Precision Explainable Artificial Intelligence Framework: Clinical Trial Tool.
FRONTIERS IN BIOSCIENCE-LANDMARK, 28 (10). ISSN 2768-6701 (2023)

[thumbnail of Saba.pdf] Text
Saba.pdf - Published Version

Download (7MB)
Item Type: Journal Article
Szerzők száma: 19
Journal or Publication Title: FRONTIERS IN BIOSCIENCE-LANDMARK
Date: 2023
Volume: 28
Number: 10
Number of Pages: 24
Publication identifier: 248
ISSN: 2768-6701
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 34434920
DOI azonosító: https://doi.org/10.31083/j.fbl2810248
Date Deposited: 2023. Dec. 15. 13:49
Last Modified: 2023. Dec. 15. 13:49
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/29105
Web of Science® Times Cited: 3 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year